Corrections to: "Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes"  by unknown
Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes
Journal of Investigative Dermatology (2009) 129, 1836; doi:10.1038/jid.2009.135
Correction to: Journal of Investigative Dermatology (2008) 128, 2646–2654; doi:10.1038/jid.2008.135
In the publication by Bu¨chau et al., there is an error in the legend to Figure 2. The corrected legend appears below,
with the figure. In addition, the callout for Figure 2d under the second heading in the text should instead be for Figure 1e.
The authors regret the error.
Improved Cutaneous Healing in Diabetic Mice Exposed to Healthy Peripheral Circulation
Journal of Investigative Dermatology (2009) 129, 1836; doi:10.1038/jid.2009.136
Correction to: Journal of Investigative Dermatology (2009) advance online publication 19 March 2009;
doi:10.1038/jid.2009.60
In the publication by Pietramaggiori et al., an incomplete legend was published for Figure 4. The legend corresponding to
portions 4c and 4d appears below.
(c) Db animals joined to EGFPþ wt partners, showed engraftment of EGFPþ endothelial cells (n¼2 per group).
Red¼CD31; green¼ EGFP; yellow¼CD31þ EGFP. Bar¼40 mm. On day 7, EGFPþ cells expressing collagen I (arrows)
were seen in db-chimera wounds when animals were joined to EGFP-wt mates (n¼ 2). Red¼ collagen I; green¼ EGFP;
yellow¼ collagen Iþ EGFP. Bar¼ 40 mm. (d) Increased presence of SDF-1 in wounds of db-chimeras compared with
db-controls (n¼3 per group). Bar¼20 mm.
The publisher regrets the error.
Interaction of Extracellular Matrix Protein 1 with Extracellular Matrix Components: ECM1 Is a Basement Membrane Protein
of the Skin
Journal of Investigative Dermatology (2009) 129, 1836–1837; doi:10.1038/jid.2009.137
Correction to: Journal of Investigative Dermatology (2008) 128, 1397–1408; doi:10.1038/sj.jid.5701231
In the publication by Sercu et al., Figures 5, 7, and 10 were incorrectly printed in black and white. The publisher regrets
the error. The figures are reprinted here in color.
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Figure 2. Pimecrolimus enhances TLR and CD14 expression in
keratinocytes. NHEKs were stimulated with vehicle control, low-dose
1,25D3 (1 nM), pimecrolimus (10 nM), or the combination of 1,25D3 and
pimecrolimus for 24 hours. (a) Gene expression of TLR1, TLR2, TLR6, and
the TLR cofactor CD14 was analyzed by real-time qPCR. (b) Western blotting
of CD14 protein expression (upper blot) in NHEKs stimulated with vehicle
(lane 1), 1,25D3 (1 nM, lane 2), pimecrolimus (10 nM, lane 3), or the
combination of 1,25D3 and pimecrolimus (lane 4) for 24 hours. Membranes
were reprobed for loading control with an anti-a-tubulin antibody (lower
blot). Protein abundance of CD14 seen in Western blot was quantified by
densitometry (bottom right).
